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Tao-Shih Hsieh,§ C.-ting Wu,†,3 and Pamela K. Geyer*,‡,††,3
*Graduate Program in Genetics, ‡Molecular and Cellular Biology Program, and ††Department of Biochemistry, University of Iowa,
Iowa City, Iowa 52242, †Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, §Department of
Biochemistry, Duke University, Durham, North Carolina 27708, and **Department of Biology, Brandeis University, Waltham,
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ABSTRACT Type II topoisomerases are essential ATP-dependent homodimeric enzymes required for transcription, replication, and
chromosome segregation. These proteins alter DNA topology by generating transient enzyme-linked double-strand breaks for passage
of one DNA strand through another. The central role of type II topoisomerases in DNA metabolism has made these enzymes targets
for anticancer drugs. Here, we describe a genetic screen that generated novel alleles of Drosophila Topoisomerase 2 (Top2). Fifteen
alleles were obtained, resulting from nonsense and missense mutations. Among these, 14 demonstrated recessive lethality, with one
displaying temperature-sensitive lethality. Several newly generated missense alleles carry amino acid substitutions in conserved residues
within the ATPase, Topoisomerase/Primase, and Winged helix domains, including four that encode proteins with alterations in residues
associated with resistance to cancer chemotherapeutics. Animals lacking zygotic Top2 function can survive to pupation and display
reduced cell division and altered polytene chromosome structure. Inter se crosses between six strains carrying Top2 missense alleles
generated morphologically normal trans-heterozygous adults, which showed delayed development and were female sterile. Comple-
mentation occurred between alleles encoding Top2 proteins with amino acid substitutions in the same functional domain and between
alleles encoding proteins with substitutions in different functional domains. Two complementing alleles encode proteins with amino
acid substitutions associated with drug resistance. These observations suggest that dimerization of mutant Top2 monomers can restore
enzymatic function. Our studies establish the ﬁrst series of Top2 alleles in a multicellular organism. Future analyses of these alleles
will enhance our knowledge about the contributions made by type II topoisomerases to development.
TOPOLOGICAL changes in chromosome structure are re-solved through the action of a wide variety of enzymes
known as topoisomerases. Among these, type II topoiso-
merases are conserved enzymes that alter DNA structure
by introducing a transient double-strand break (DSB) in one
DNA strand and passing a second DNA strand through the
cleaved strand (Wang 2002; Nitiss 2009a). This catalytic cycle
involves the covalent attachment of topoisomerase II to DNA,
a reversible reaction that ends by ligation of the DSB. For-
mation of an enzyme–DNA intermediate protects the DNA
ends and prevents activation of a DNA damage checkpoint.
Type II topoisomerases are homodimeric proteins (Schoefﬂer
and Berger 2008; Collins et al. 2009; Nitiss 2009a). Each mono-
mer is composed of distinct domains that cooperate to alter
DNA topology (Figure 1). The amino-terminal ATPase domain
is responsible for ATP binding and hydrolysis, which promotes
dimer formation and regulates DNA opening and closing.
Flanking the ATPase domain is the Transducer domain (TDD),
which signals ATP binding to the catalytic core. Following
the TDD is the catalytic core, composed of two domains
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required for DNA breakage and religation. Of these, the
Topoisomerase/Primase (TOPRIM) domain contains a triad
of acidic amino acids that are required for the DNA cleavage
reaction and the Winged helix domain (WHD) contains the
active-site tyrosine, which forms the covalent linkage with
DNA. The Tower domain (TD) and Coiled-coiled domain
(CCD) follow the catalytic core and together regulate the
passage of one DNA strand. Finally, the carboxyl-terminal
domain (CTD) is dispensable for catalytic activity in vitro,
but regulates nuclear accumulation and interactions with
partner proteins in vivo (Collins and Hsieh 2009). Among
these domains, the CTD is the least conserved among eukar-
yotes, differing both in length and in sequence (Austin et al.
1993). Structural domains within dimeric type II topoiso-
merases are formed by contributions of both monomers
(Liu and Wang 1999; Classen et al. 2003), which facilitates
coupling of ATP hydrolysis to conformational changes involved
in altering DNA structure.
In light of the function of type II topoisomerases, it is
not surprising that these enzymes are structurally con-
served and encoded by essential genes (Nitiss 2009a). The
yeast and Drosophila genomes each contain a single gene,
called Topoisomerase 2 (Top2). Mammalian genomes con-
tain two Top2 genes, Top2A and Top2B, which encode the
differentially expressed paralogs Top2a and Top2b, respec-
tively (Austin and Marsh 1998). Top2a is found in prolifer-
ating cells, while Top2b is found ubiquitously, with elevated
levels in terminally differentiated cells (Capranico et al. 1992;
Watanabe et al. 1994). Interestingly, yeast Top2 mutants are
rescued by expression of the Drosophila or human Top2 pro-
tein (Wyckoff and Hsieh 1988; Jensen et al. 1996), illustrat-
ing the strong functional conservation among eukaryotic
type II topoisomerases.
Eukaryotic type II topoisomerases resolve entwined DNA
strands and relax supercoiled structures that arise from
the action of DNA polymerases. Genetic knockdown and
chemical inhibitor studies have revealed that loss of Top2
causes chromosome missegregation and DNA damage during
mitosis due to a failure to resolve sister chromatids and
centromeres (Chang et al. 2003; Baxter and Difﬂey 2008;
Coelho et al. 2008; Gonzalez et al. 2011). Some of these
defects may result from altered chromosome architecture
(Uemura et al. 1987; Buchenau et al. 1993; Chang et al. 2003;
Coelho et al. 2008; Stanvitch and Moore 2008), as Top2a
is a major structural component of mitotic chromosomes
(Earnshaw et al. 1985; Adachi et al. 1991; Maeshima and
Laemmli 2003). A role in global chromosome architecture
is further suggested by studies in Drosophila, where Top2
may be involved in somatic homolog pairing (Williams et al.
2007) and insulator function (Ramos et al. 2011). The es-
sential mitotic requirement for type II topoisomerases has
made these enzymes important targets for chemotherapy
against a number of cancers (Nitiss 2009b; Chikamori et al.
2010).
Our interest in Drosophila Top2 began with an earlier
analysis demonstrating that compromising the function of
this protein perturbs homolog pairing in cell culture (Williams
et al. 2007). Here, we describe a genetic screen to generate
a series of ethyl methanesulfonate (EMS)-induced Top2
alleles, as we reasoned that hypomorphic and null mutations
would provide a useful resource that would complement the
extant Top2 P-element insertion alleles (Bloomington Stock
Center). In total, we identiﬁed 15 new alleles. Among these,
14 demonstrated recessive lethality, with one of these muta-
tions displaying temperature sensitivity. Lethal alleles resulted
from nonsense and missense substitutions in the protein-
coding region, representing the ﬁrst non-deletion, non-
insertional Top2 alleles generated in Drosophila. Missense
substitutions were in key functional domains of Top2 and
included changes in residues associated with resistance to
chemotherapeutic drugs (Wu et al. 2011). Inter se crosses
between lethal missense alleles uncovered interallelic com-
plementation, wherein trans-heterozygous Top2mutant adults
were generated. These adults were morphologically normal,
although these ﬂies showed delayed development and were
female sterile. Interallelic complementation extended to
crosses of strains carrying alleles encoding drug-resistant
analogs of Top2. Taken together, these ﬁndings suggest that
Figure 1 Structure of the Top2 locus. (A) Top2
is located on chromosome 2L between the
uncharacterized upstream CG10026 gene and
the essential downstream RanGap gene.
Shown are the structures of three Top2 deﬁ-
ciency chromosomes used in these studies.
Top2Df9043 is a 14.8-kb deletion allele (dashed
line) that removes Top2, RanGap, Hs2st (the
gene within the RanGap intron), and
CG10237. Top2Df17 is an 3.6-kb deletion al-
lele (dashed line) that removes only Top2
sequences and retains 600 bp of the starting
P element (Top2EP). Top2Df35 is a deletion allele
that removes Top2 sequences, but has un-
known limits (dotted line). Promoters are indi-
cated by bent arrows and exons are represented by shaded rectangles. (B) P[Top2-w+] is a P transposon that carries white+ (not shown), a 7.1-kb
genomic fragment encompassing the entire Top2 gene, and the 59 region of CG10026 and the 39 largely untranslated region of RanGap. The coding
region of the Top2 gene is annotated to indicate locations of the ATPase domain, the Transducer domain (TDD), the Topoisomerase/Primase (TOPRIM)
domain, the Winged helix domain (WHD), the Tower domain (TD), the Coiled-coiled domain (CCD), and the carboxyl-terminal domain (CTD).
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dimerization of some defective subunits can restore the
in vivo activity of Top2. In brief, we have generated a new
resource for investigating Top2 function.
Materials and Methods
Drosophila stocks and culture conditions
Flies were maintained at 25 at 70% humidity on standard
Drosophila cornmeal, yeast, sugar, and agar medium with
r-hydroxybenzoic acid methyl ester as a mold inhibitor. All
crosses were performed at 25, unless otherwise speciﬁed.
Df(2L)Exel9043 (Bloomington Stock Center, BL 7913) is a
14.8-kb deletion on chromosome 2 that removes several genes
including Top2, RanGap, Hs2st, and a portion of CG10237
(FlyBase, http://ﬂybase.bio.indiana.edu/; Figure 1A). We
refer to this deletion as Top2Df9043. Top2mutant alleles were
carried over the balancer chromosome CyO-Df(2R)B80, y+
balancer (BL 4542), referred to as CyO, y+. The Top2Df17
and Top2Df35 deﬁciencies were generated by excision of an
existing P element (Top2EP). Top2Df17 contains a 3580-bp
deletion within the Top2 coding region, with 590 bp remaining
of the P element (Figure 1A). The breakpoints of Top2Df35
have not been mapped.
Mutagenic screen for the identiﬁcation of Top2
mutant alleles
The strategy for isolating Top2 alleles is shown in Figure 2.
Two- to four-day-old y1#8/Y; dp cn bw/dp cn bw males were
desiccated for 12–14 hr and then fed 25 mM EMS in 10%
sucrose (w/v). This mutagen was chosen as it largely produ-
ces nucleotide substitutions resulting from guanine alkylation
(Bentley et al. 2000). After 24 hr of feeding, mutagenized
males were transferred to bottles with standard food, allowed
to recover for 10–12 hr, and mated for 24 hr with y2;
Top2Df17 or Df35/CyO females. Mated females were trans-
ferred to fresh bottles daily for 3–4 days. F1 females of the
genotype y2/y1#8; (dp cn bw)*/Top2Df17 or Df35 were scored for
wing and body pigmentation. F1 males of the genotype y2/Y;
(dp cn bw)*/CyO were singly mated in vials to y2/y2;
Top2Df17 or Df35/CyO females. The resulting F2 progeny were
screened, vial by vial, for decreased viability, as determined
by an absence or reduced numbers of straight-winged ﬂies.
The y2/Y; (dp cn bw)*/CyOmales from such vials were back-
crossed to y2/y2; Top2Df17 or Df35/CyO females to conﬁrm the
decreased viability of straight-winged ﬂies and to generate
stocks carrying the putative Top2 mutations (Top2m). Stocks
of putative Top2m mutations were established by subse-
quent balancing of the Top2m chromosome with the CyO,
y+ chromosome, with 19 stocks established (Supporting In-
formation, Table S2). Most crosses involved Top2m alleles
balanced with the CyO, y+ chromosome; exceptional crosses
involved Top2m alleles balanced with the CyO chromosome.
These putative mutations were named based on the tester
deﬁciency chromosome used in their identiﬁcation, with those
using the Top2Df17 tester named Top217-x and those using the
Top2Df35 tester named Top235-x. The original tester deﬁciency
chromosome for Top235-12 was unknown; this allele was
arbitrarily assigned to the Top2Df35 group.
All putative mutations were rescreened by crossing
y1w67c23; Top2m/CyO, y+ males or virgin females to ﬂies
carrying an independent Top2 deﬁciency chromosome
(y1w67c23; Top2Df9043/CyO, y+). Crosses that produced no
straight-winged ﬂies were considered to contain new Top2
mutations. Next, we tested whether a wild-type Top2 gene
rescued the recessive lethality associated with the Top2m
alleles. To this end, we generated transgenic ﬂies that carried
an insertion of a genomic rescue transposon, P[Top2-w+], on
the third chromosome. P[Top2-w+] carries a mini-white gene
and a 7.1-kb HindIII to XbaI genomic fragment that in-
cludes the wild-type Top2 gene and part of the CG10026
gene (Figure 1B). As a control, we demonstrated that
P[Top2-w+] rescued the recessive lethality associated with
Top2Df17/Top2Df35 (Table S3), wherein Top2Df17/Top2Df35;
P[Top2-w+]/+ individuals were produced at 86% of the
Top2Df17 or Df35/CyO, y+ class.
Characterization of newly generated Top2
mutant alleles
Several studies were conducted to characterize the new
Top2m alleles. First, we determined whether alleles displayed
parent-of-origin effects by crossing y1w67c23; Top2m/CyO, y+
males or females to y1w67c23; Top2Df9043/CyO, y+ individuals
of the opposite sex and scoring whether Top2m/Top2Df9043
adults survived. Second, we assessed whether Top2m alleles
were temperature sensitive by crossing y1w67c23; Top2m/
Figure 2 Strategy used in the EMS screen. Males of the genotype y1#8/Y;
dp cn bw/dp cn bw were fed EMS and mated to y2/y2; TopDf17 or 35/CyO
virgin females. In the F1 screen, y2/y1#8; (dp cn bw)*/TopDf17 or 35 females
were screened for altered complementation between y alleles. In the F2
screen, F1 males carrying a mutagenized second chromosome in trans to
the CyO balancer were crossed to virgin y2/y2; Top2Df17 or 35/CyO females.
Vials were screened for absent or reduced numbers of straight-winged
(Cy+) ﬂies. * indicates the mutagenized chromosome. Of 3000 chromo-
somes screened, 30 putative Top2 alleles were identiﬁed, with 15 corre-
sponding to bona ﬁde alleles.
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CyO, y+ females to y1w67c23/Y; Top2Df9043 /CyO, y+ males at
room temperature for 2 days, after which time progeny were
placed at 18. Progeny emerging from these crosses were
scored daily to determine whether growth at 18 generated
Top2m/Top2Df9043 adults. Third, we assessed complementa-
tion between the Top2m alleles, performing inter se crosses
between y1w67c23; Top2m/CyO, y+ or y2; Top2m/CyO mutants
at 25, with initial experiments scoring progeny every 2–3 days
(data not shown). Complementation was observed between
several different pairs of alleles, as Top2m1/Top2m2 adults
were generated, which we call Top2-complementing adults.
Crosses producing Top2-complementing adults were retested,
with progeny screened daily. Fourth, we tested whether any
of the Top2 mutations represented hypomorphic alleles. In
these studies, we assessed partial Top2 function by examin-
ing viability of Top2m/Top2Df9043 larvae. Flies from each
lethal Top2 mutant strain (y1w67c23/y1w67c23; Top2m/CyO,
y+) were crossed to y1w67c23/Y; Top2Df9043/CyO, y+ ﬂies
and the y1w67c23; Top2m/Top2Df9043 second- and third-instar
larvae were collected, using the absence of pigmentation in
the mouth hooks and denticle belts to identify the correct
genotype. For each cross, at least 100 larvae were selected
and placed in vials, with no more than 25 larvae per vial,
and allowed to develop at 25 under uncrowded conditions.
The total numbers of individuals advancing to later stages
were scored, with the percentage of survival at each stage
determined by dividing the number of individuals obtained
by the total number of larvae placed in each vial, multiplied
by 100. Top2m alleles were considered hypomorphic if
Top2m/Top2Df9043 larvae showed greater survival than did
larvae from control crosses performed using conﬁrmed null
alleles. Fifth, the fertility of Top2 complementing males
and females was assessed. In these studies, 8–10 y1 w67c23;
Top2m1/Top2m2 males or females were crossed to 10–15 y1
w67c23; Sco/CyO ﬂies of the opposite sex. Crosses were trans-
ferred every 2–3 days. Top2-complementing males were
considered fertile if adults were produced from the cross.
Top2-complementing females were considered fertile if
they produced eggs that hatched. Crosses of ﬂies from the
parental line (y1#8; dp cn bw) were studied in parallel, as a
control (data not shown).
Molecular characterization of Top2 alleles
Genomic DNA was isolated from heterozygous y1w67c23;
Top2m/Top2Df9043 larvae and PCR ampliﬁed using primers
covering nine overlapping regions encompassing the Top2
protein-coding region. PCR products were puriﬁed using the
QIAquick PCR puriﬁcation kit (QIAGEN, Valencia, CA; no.
28104) and sequenced at the University of Iowa DNA Core
Facility. Primers are listed in Table S1. Western analysis was
used to determine the level of Top2 protein generated in
each strain. For these studies, proteins were extracted from
a collection of brain, imaginal disc, and salivary gland tis-
sues dissected from 10 Top2m/Top2Df9043 larvae. Two pri-
mary antibodies were used to detect Top2: rabbit anti-Top2
(T. Hsieh) at 1:10,000 (Figure 3) and rabbit anti-Top2
(D. Arndt-Jovin) at 1:4000 (data not shown). HRP-conjugated
goat anti-rabbit IgG secondaries [Bio-Rad, Hercules, CA; no.
172-1019] were used at 1:20,000.
Polytene chromosome and
immunohistochemical analyses
Salivary gland polytene chromosomes were studied to deﬁne
the impact of loss of Top2 on chromosome structure. Females
of the genotype y1w67c23/y1w67c23; Top217-5 or 35-15/CyO, y+
were crossed to y1w67c23/Y; Top2Df9043/CyO, y+ males at
room temperature for 2 days and then placed at 18, accord-
ing to previously described methods (Johansen et al. 2009).
Polytene chromosomes stained with antibodies against MSL1,
MLE, and JIL-1 were prepared using the conventional squash
protocol, while those stained with H4K16ac were prepared
using the acid-free method. For each genotype, squashes
were done on at least 10 salivary gland pairs, dissected from
larvae obtained from at least two independent crosses. Over
100 nuclei were examined for each genotype.
The effects of Top2 loss on imaginal disc and ovary de-
velopment were studied. Tissues were dissected into 1·
phosphate-buffered saline (PBS) solution and ﬁxed in 3%
paraformaldehyde (Electron Microscopy Sciences; no. 15710)
for 20 min. Each immunohistochemical analysis was com-
pleted at least twice, with each analysis including tissues
obtained from at least 8–10 individuals of each genotype.
After tissues were blocked in PBT + 5% normal goat serum
(Vector Laboratories, Burlingame, CA; no. S-1000), they were
incubated overnight with primary antibodies at 4. Follow-
ing washes, tissues were stained with secondary antibodies
for 2–3 hr and with DAPI (1 mg/ml in PBT) for 5–10 min.
Samples were mounted in Vectashield (Vector Laboratories;
H1000), imaged with a Zeiss (Thornwood, NY) 710 confocal
microscope, and processed using ImageJ.
Primary antibodies used in the immunohistochemical
analyses include rabbit anti-Phospho-Histone H3(pS10)
(Epitomics; no. 1173-1) at 1:500, rabbit anti-H4K16ac at
1:50 (Active Motif; no. 39929), chicken anti-JIL-1 at 1:100
(K. Johansen), mouse anti-Lamin Dm0 [Developmental Stud-
ies Hybridoma Bank (DSHB), University of Iowa; ADL84.12]
at 1:500, rabbit anti-Lamin Dm0 (P. Fisher), rabbit anti-MSL1
at 1:100 (M. Kuroda), rabbit anti-MLE at 1:100 (M. Kuroda),
rabbit anti-Vasa (Santa Cruz; no. sc-30210) at 1:500, and
mouse anti-Spectrin (DSHB; no. 3A9) at 1:50. The secondary
Alexa Fluor (AF) antibodies (Invitrogen; Molecular Probes,
Eugene, OR) were used at a 1:500 dilution, including AF488
goat anti-rabbit (A11008), AF568 goat anti-rabbit (A11011),
AF488 goat anti-mouse (A11001), AF568 goat anti-mouse
(A11004), AF488 goat anti-chicken (A11039), and AF568
goat anti-chicken (A11041).
Results and Discussion
An EMS screen identiﬁed new Top2 alleles
Our screen was designed to recover Top2 alleles in the F1 and
F2 generations (Figure 2). In the F1 generation, we sought
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putative Top2 alleles by screening for alteration of a pheno-
type that depends on somatic homolog pairing, while in the
F2 generation, putative Top2 alleles were identiﬁed by their
failure to complement a chromosome carrying a deletion of
Top2. For this mutagenesis, we used EMS, which was fed to
males that were isogenic for a second chromosome carrying
the wild-type Top2 gene and the dp, cn, and bw markers.
Following EMS treatment, males were crossed to females
bearing one of two deletion alleles of Top2, Top2Df17 or
Top2Df35, in trans to the CyO balancer chromosome carrying
a wild-type Top2 gene and the dominant Curly wing marker.
In the F1 generation, we looked for loss or enhancement
of pairing-dependent gene expression of the X-linked yellow
(y) cuticle pigmentation gene. In particular, F1 Cy+ females
were examined for changes in complementation between
a paternally contributed y1#8 allele, which lacks the y pro-
moter and is a complete null, and a maternally contributed
y2 allele, which has the y wing and body enhancers blocked
by a chromatin insulator (Geyer et al. 1990; Morris et al.
1999). In a Top2+ background, y2/y1#8; (dp cn bw)*/
Top2Df17 or Df35 females were expected to show dark, nearly
wild-type pigmentation because chromosome pairing per-
mits the wing and body enhancers of y1#8 to act in trans
on the promoter of y2. If a Top2mutation was recovered that
affected pairing, then altered wing and body pigmentation
would be expected. Importantly, females carrying y2 have
darkly pigmented bristles regardless of pairing status, which
enabled us to distinguish any exceptional y2/y1#8; (dp cn
bw)*/Top2Df17 or Df35 females with reduced pigmentation
from y1#8/y1#8; (dp cn bw)*/Top2Df17 or Df35 females arising
from nondisjunction of the X chromosome.
From 2653 F1 females, we identiﬁed 12 straight-winged
females that had altered cuticle pigmentation. At least 4 of
these females showed an unambiguous, uniform light cuticle
color, resembling females in which y pairing had been dis-
rupted (Chen et al. 2002; Ou et al. 2009). Seven of these
exceptional females were successfully mated and all pro-
duced males with the light cuticle pigmentation characteristic
Figure 3 Analyses of protein production in
Top2 mutations. (A) The locations of the non-
sense and missense mutations in the lethal
Top2 alleles are shown relative to the Top2 pro-
tein domain structure. Abbreviations are de-
scribed in Figure 1. (B and C) Top2 protein
levels were determined by Western analysis of
proteins extracted from Top2m/Top2Df9043
third-instar larvae carrying missense (B) and
nonsense (C) alleles. Westerns were probed
with antibodies generated in the Hsieh labora-
tory. Antibodies against a-tubulin served as
a loading control. One larval equivalent was
loaded per lane. Solid arrowheads indicate the
position of the full-length Top2. The open ar-
rowhead marks the position of a full-length
protein obtained from Top235-14/Top2Df9043 lar-
vae, even though the Top235-14 nonsense allele
is predicted to encode a protein of 20 kDa. The
absence of a full-length band in protein extracts
obtained from lines carrying other nonsense
alleles suggests that this band represents con-
text-speciﬁc readthrough of the nonsense codon.
Asterisks mark the position of a cross-reacting
band that was routinely observed.
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of the y1#8 allele, which was presumed to have been in-
herited from their mother. The recovery of such males is
consistent with the parental exceptional females being y2/
y1#8; (dp cn bw)*/Top2Df17 or Df35, with such females carry-
ing a mutant Top2 allele that encoded a protein that was
unable to promote chromosome pairing but provided adult
viability. Alternatively, it may be that these exceptional
females arose from X chromosome nondisjunction, wherein
nondisjunction of y2 in conjunction with loss of y1#8 gener-
ated homozygous y2 tissues except in the germline, which
remained heterozygous for y1#8 and y2. Unfortunately, all
subsequent crosses with the progeny of these exceptional
females failed to recapitulate the reduced pigmentation of
the original females.
In the F2 generation, we looked for recessive lethal or
semilethal alleles of Top2. Here, F1 y2/Y; (dp cn bw)*/CyO
males, each representing a single mutagenized second chro-
mosome, were singly crossed in vials to y2/y2; Top2Df17 or Df35/
CyO females, representing two different tester Top2 deﬁ-
ciency chromosomes. Next, each vial was scored for the
absence or reduced numbers of straight-winged progeny,
consistent with the presence of a de novo lethal or semilethal
Top2 allele. Of 3000 crosses, 30 putative Top2m alleles were
identiﬁed. From these putatives, we successfully established
19 y1w67c23; Top2m/CyO, y+ stocks (Table S2), while 11
putatives either were sterile or produced unhealthy stocks
that were subsequently lost. Each of the 19 putative alleles
was tested in trans to Top2Df9043, a Top2 deﬁciency that was
generated independently of Top2Df17 and Top2Df35, and a to-
tal of 15 were conﬁrmed (Table S2). Fourteen demonstrated
complete lethality in trans to Top2Df9043, while the remain-
ing mutation, Top235-4, showed 25% of the expected class
when transmitted maternally and 87% when transmitted
paternally. To ensure that the lethality of the newly gener-
ated mutations was due to mutation of Top2, we tested
whether the P[Top2-w+] transgene that carried a wild-type
Top2 gene rescued the viability of Top2m/Top2Df35 ﬂies. Of
note, Top235-4 was not tested in this study, due to the high
viability observed upon paternal transmission. In all cases,
viable Top2m/Top2Df35; P[Top2-w+]/+ adults were obtained
(Table S3), conﬁrming that lethality was due to mutations
in Top2. In total, 15 lethal or semilethal Top2 alleles were
generated.
Several parameters contribute to gene mutability, in-
cluding the length of the transcription unit, the size of the
protein, and different tolerances among proteins for altered
amino acid sequence. Among these, a recent screen using
Drosophila demonstrated that the best predictors of muta-
bility are length and conservation of the protein (Cooper
et al. 2010). Based on the number of recessive lethal muta-
tions identiﬁed after screening 3000 chromosomes, these
investigators predicted that EMS generates one lethal muta-
tion for every 73 evolutionarily conserved amino acids.
Based on this information, we estimated that our screen
should have generated 13 new Top2 alleles, as Drosophila
Top2 is a 167-kDa protein that displays 67% similarity to
human Top2. Our recovery of 14 lethal mutations is in re-
markable agreement with the predicted value, arguing that
our identiﬁcation of a large number of new Top2 alleles
reﬂects the size and high conservation of functional domains
throughout the protein.
Top2 missense alleles carry amino acid substitutions
in critical functional domains
To deﬁne the molecular lesions associated with the Top2
mutations, genomic sequences encompassing the coding re-
gion were PCR ampliﬁed and sequenced. As a reference, we
sequenced the coding region of the Top2 gene from the
parental strain, identifying two base pair changes relative
to the sequence of the Top2 gene curated at NCBI; one is
a silent change (+G3040A, E565E) and one produces a con-
servative amino acid substitution (+C5628T, A1401V) in
a less conserved region of Top2 (Crenshaw and Hsieh
1993). These data indicate that the sequence of the Top2
coding region is largely unchanged between strains. As an
additional control, we sequenced the Top2 coding region
from four putative Top2 mutations that had been identiﬁed
in our original screen, but were found to complement
Top2Df9043 in secondary analyses (Table S2). We predicted
that these alleles would be unlikely to harbor changes in
Top2. As expected, the coding region in all four was identi-
cal to that in the parental strain (data not shown). Sequence
analyses of the Top2 coding region in the 15 lethal or semi-
lethal Top2 mutations revealed that 3 alleles carried non-
sense mutations, 1 allele carried a missense and a nonsense
mutation, 1 allele carried 3 missense mutations, and 10
alleles carried single missense mutations (Table 1). In all
cases, missense alleles encoded Top2 proteins with one
amino acid substitution in a residue conserved with human
Top2a, with 6 alleles that showed alterations in residues
found to be invariant among all sequenced eukaryotic type
II topoisomerases. The missense mutations in our alleles
were clustered in three functional domains, including the
ATPase, WHD, and TOPRIM domains (Figure 3A). Based
on structural information provided from studies of human
Top2a (Wei et al. 2005) and etoposide bound to Top2b (Wu
et al. 2011), we predict that Top235-5 may alter the ATP-
binding pocket; Top217-3 may alter DNA binding; and
Top235-1, Top235-6, and Top235-12 might display altered bind-
ing to the Top2 inhibitor etoposide.
We determined the levels of Top2 protein produced in
the 14 Top2 strains that carry lethal alleles. Our Western
analyses used two polyclonal antibodies raised against the
full-length Top2 protein, which was especially important for
optimizing the detection of mutant proteins obtained from
strains carrying nonsense mutations. Similar results were
obtained using both antibodies (Figure 3B, Table 1, and data
not shown). We found that Top2 was at low levels or absent
in 7 strains, including all 4 strains carrying nonsense muta-
tions and 3 strains carrying missense mutations, while the
remaining 7 strains carrying missense mutations displayed
intermediate to high protein levels. In general, Top2 proteins
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that carried changes in the TOPRIM domain accumulated
high levels of protein, while those with amino acid substitu-
tions in the ATPase domain or WHD produced varying levels
of protein. Top235-3 produces low levels of protein even
though the translation initiation ATG codon is mutated. This
protein may arise from a low frequency of initiation at the
nearby in-frame ATG codon located 12 codons downstream of
the bona ﬁde initiator, leading to a loss of the ﬁrst few amino
acids in Top2. A low level of full-length Top2 was also found
in protein extracts obtained from Top235-14/Top2Df9043 larvae,
a surprising ﬁnding because Top235-14 carries a nonsense mu-
tation at codon 186 and is predicted to generate a 20-kDa
protein. The observed full-length protein might result from
context-speciﬁc readthrough of the 186 nonsense codon,
a possibility supported by the absence of this band in extracts
obtained from other lines carrying nonsense mutations. Fur-
ther, recent ﬁndings suggest that stop codon readthrough in
Drosophila is more prevalent than previously realized (Jungreis
et al. 2011). We were surprised by the low level of protein
produced by the Top235-2 allele that carries a nonsense mu-
tation of codon 1300 because a similarly sized truncated
Drosophila Top2 protein was functional in vitro and comple-
mented mutations of the yeast Top2 gene (Crenshaw and
Hsieh 1993). A possible explanation may lie in the observa-
tion that a nuclear localization signal is present in the last 60
amino acids (Crenshaw and Hsieh 1993), amino acids that
are lost in the Top235-2 protein. The absence of a nuclear
localization signal in Drosophila may prevent Top235-2 nu-
clear entry and lead to protein degradation. Taken together,
our Western analyses show that some of the lethal Top2
alleles accumulate high levels of protein. Previous studies
in Saccharomyces cerevisiae have shown that lethality result-
ing from Top2 depletion and lethality caused by catalytic
inactivation of Top2 result from different mechanisms
(Baxter and Difﬂey 2008). Here we demonstrate that our
collection of Top2 mutations includes those that produce no
protein and those that produce near wild-type levels of
a functionally compromised protein. Thus, our mutations
have the capacity to elucidate how Top2 depletion and in-
activity cause different mechanisms of lethality.
Top2 missense alleles include temperature-sensitive
and hypomorphic mutations
Temperature-sensitive alleles are a useful resource for in vivo
functional studies. As missense mutations occasionally cause
temperature sensitivity in protein function, we determined
whether any of our Top2 mutations were temperature sen-
sitive. We crossed y1w67c23/Y; Top2m/CyO, y+ females to
y1w67c23; Top2Df9043/CyO, y+ males, collected eggs for 2
days at room temperature, and then transferred progeny
to 18 for the remainder of development. These studies
identiﬁed one genotype, Top217-2/Top2Df9043, that produced
adults at the lower temperature. Based on the number of Top2m
heterozygous siblings, we estimate that 29% of Top217-2/
Top2Df9043 ﬂies survived to adulthood (Table S2 and Figure
4A). Although Top217-2/Top2Df9043 females died shortly af-
ter emerging from their pupal cases, adult males survived
for several days. To determine whether continued growth at
18 was essential for Top217-2/Top2Df9043 survival, y1w67c23/
Y; Top217-2/CyO, y+ females were crossed to y1w67c23;
Top2Df9043/CyO, y+ males at 18 and progeny were shifted
to 25 at different developmental times. We found that
a shift to 25 at 1 day (embryonic shift) or 12 days (pupal
shift) resulted in a loss of adults (Figure 4A), suggesting that
Top2 function is required both early and late in development,
consistent with an essential function throughout development.
Table 1 Properties of Top2 alleles
Allele name Amino acid changea Affected domainb
Protein
accumulationc
Interallelic
complementationd
17-1 S791F WHD +/2 Yes
17-2 I198N ATPase +/2 No
17-3 L471Q TOPRIM +++ Yes
17-5 L318Q, Q1201e NA +/2 No
17-6 Y592N TOPRIM +++ Yes
17-7 L774e NA — No
35-1 R197C, C347S, P465S ATPase, TDD, TOPRIM +++ Yes
35-2 K1300e NA +/2 No
35-3 M1L NA + No
35-4 T712I WHD ND ND
35-5 D134G ATPase +++ Yes
35-6 S743F WHD ++ No
35-12 G740E WHD ++ No
35-13 R773H WHD ++ Yes
35-14 Q186e NA — No
ND, not determined; NA, not applicable.
a Boldface type: invariant between human Top2a and -b, mouse Top2a and -b, and yeast Top2.
b TDD, Transducer domain; TOPRIM, Topoisomerase/Primase domain; WHD, Winged helix domain.
c Protein accumulation as assayed by Western analysis (+++, protein levels equal to wild type; ++, intermediate levels; +, low levels; +/2, very low levels; —, no protein
relative to wild-type).
d Complementation with other Top2 alleles.
e Denotes nonsense mutation.
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Considering that Top217-2 encodes a full-length protein with
a substitution in the highly conserved motif in the ATPase
domain (I198N; Table 1), it is possible that the temperature
sensitivity of Top217-2 results from defects associated with
an inability of ATP binding or hydrolysis, properties needed
to impart conformational changes needed to alter DNA to-
pology. Alternatively, improved survival at the lower temper-
ature may result from changes in Top217-2 accumulation,
resulting from altered translation or degradation. Cold-
and heat-sensitive Top2 mutants have been previously
isolated in yeast (Thomas et al. 1991). These mutations
resulted from missense mutations in conserved residues lo-
cated outside of the ATPase domain and were clustered near
the active site. These data suggest that missense mutations
in multiple functional Top2 domains can generate tempera-
ture sensitivity.
We were interested in deﬁning whether our newly gener-
ated Top2 alleles represent complete or partial loss of function.
To this end, we assessed the viability of Top2m/Top2Df9043
mutants, predicting that compared to complete loss of
Top2 function, partial loss of function would permit in-
creased survival. We crossed y1w67c23/y1w67c23; Top2m/
CyO, y+ females to y1w67c23/Y; Top2Df9043/CyO, y+ males
and followed development of y1w67c23; Top2m/Top2Df9043
larvae, identiﬁed by the absence of cuticle pigmentation.
As a control, we tested two trans-heterozygous null geno-
types (Top2Df17/Top2Df9043 and Top2Df35/Top2Df9043), antic-
ipating that these genotypes would show extensive lethality
prior to pupation, as previous studies have shown that Top2
alleles that produced undetectable levels of protein dis-
played high mortality in second-instar larvae, with ,5%
escaping into the third-instar larval stage (Ramos et al. 2011).
Unexpectedly, we found that 49–66% of Top2Df17 or Df35/
Top2Df9043 null larvae survived to pupation (Table 2), imply-
ing a lethal phase that is later than previously reported. Sim-
ilar results were obtained for Top2m/Top2Df9043 mutant
larvae carrying nonsense alleles, wherein 38–66% of mutant
larvae survived to pupal stages (Table 2). Finally, we studied
Top2m/Top2Df9043 larvae carrying Top2 missense alleles. We
found that seven Top2m/Top2Df9043 genotypes demonstrated
signiﬁcantly enhanced survival relative to the known null
genotypes, wherein 80–92% of mutant larvae became pupae
(P , 0.04; Table 2). We note that one genotype, Top235-3/
Top2Df9043 (P , 0.0002; Table 2) demonstrated signiﬁcantly
decreased survival relative to the null genotypes. Whether
this difference reﬂects an unrelated inﬂuence of the genetic
background or a special feature of Top235-3 is unclear. For
example, Top235-3 may exert antimorphic effects, as it is
predicted to carry a small amino-terminal deletion. Based on
these data, we conclude that several newly identiﬁed mis-
sense mutations include hypomorphic Top2 alleles.
Lethality during pupal stages of development suggested
that Top2 mutants might carry defects in imaginal discs,
which are ultimately responsible for generating adult tis-
sues. In particular, we surmised that mutations in Top2
might interfere with the growth of imaginal discs, as pre-
vious studies in Drosophila cell culture have demonstrated
that chemical inhibitors of Top2 decrease mitosis (Coelho
et al. 2008). To test this postulate, we studied imaginal disc
tissues isolated from multiple Top2 mutant strains, which
revealed that imaginal discs and brains were larger in strains
carrying hypomorphic alleles than in strains carrying null
Figure 4 Top217-2 is a temperature-sensitive allele. (A) Temperature-shift
experiments revealed that one Top2 mutation, Top217-2, was tempera-
ture sensitive. Once identiﬁed, the developmental requirement for Top2
was determined by crossing Top217-2/CyO, y+ ﬂies to Top2Df9043/CyO, y+
ﬂies at 18 and shifting to 25 at 1, 12, or 27 days. The numbers of
Top217-2/Top2Df9043 adults were counted, with percentage of survival
estimated from the number of Top217-2 or Df9043/CyO, y+ siblings. Only
Top217-2/Top2Df9043 individuals raised continuously at 18 reached adult-
hood, suggesting that Top2 is required throughout development. The
Top217-2/Top2Df9043 females died shortly after eclosion. (B and C) Top2
is required for development of third-instar larval brains and imaginal discs.
Tissues were isolated from Top2+/Top2Df9043, Top217-2/Top2Df9043, and
Top217-6/Top2Df9043 mutants, carrying hypomorphic missense alleles. Lar-
vae were raised at a nonpermissive (25) or permissive (18) temperature
(B and C, respectively). Tissues were stained with the DNA stain DAPI
(grayscale) and antibodies against Phospho-Histone H3(pS10) (green) to
identify dividing cells. Images are shown as a maximum projection of
a confocal Z-stack. Bar, 100 mm.
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alleles. For example, Top217-6/Top2Df9043 larvae that produce
high levels of mutant Top2 protein contain near wild-type–
sized brains and small discs (Figures 3B and 4B), although
these tissues display an altered cellular organization (data not
shown). In contrast, Top217-2/Top2Df9043 larvae that produce
very low levels of a mutant protein contain small brains and
no imaginal discs when grown at the nonpermissive temper-
ature, but larger brains and discs when grown at the permis-
sive temperature (Figures 3B and 4B). To assess the level of
mitosis in brains and imaginal discs obtained from Top217-6/
Top2Df9043 and Top217-2/Top2Df9043 larvae, dissected tissues
were stained with an antibody against phosphorylated serine
10 of histone H3, which is a highly selective marker for mi-
totic cells (Hendzel et al. 1997). These experiments revealed
that the reduced size of brains and discs correlates with de-
creased staining of phosphorylated serine 10 of histone H3
(Figure 4, B and C), consistent with reduced levels of mitosis.
Taken together, these data suggest that defects in imaginal
disc growth may contribute to pupal lethality.
Loss of Top2 alters polytene chromosome structure
We studied the polytene chromosomes isolated from larval
salivary glands to examine how loss of Top2 affects chromo-
some structure. These chromosomes contain 1000 aligned
DNA strands, providing a powerful system for directly visu-
alizing interphase chromosomes. Here we studied two null
or nearly null Top2 genotypes, Top217-5/Top2Df9043 and
Top235-14/Top2Df9043. Polytene chromosomes isolated from
these female and male Top2 mutant larvae were fragile and
displayed a diffuse DNA-banding pattern (Figure 5). This
phenotype was particularly apparent for the male X chromo-
some, which displayed a “puffy,” decondensed structure,
reminiscent of the structure associated with mutations in
genes encoding chromatin-modifying proteins (Figure 5,
A–C and A9–C9) (Deuring et al. 2000; Wang et al. 2001;
Badenhorst et al. 2002; Spierer et al. 2005; Furuhashi
et al. 2006; Bai et al. 2007; Grau et al. 2008). These obser-
vations suggest that loss of Top2 affects global chromosome
structure, with the male X showing the greatest sensitivity
within the genome.
The response of the male X chromosome to Top2 loss
suggested a connection to the dosage compensation (DC)
pathway. A possible connection to the DC pathway was fur-
ther supported by the shared phenotype associated with
hypomorphic mutations of JIL-1, which encodes a kinase
component of the MSL complex that is responsible for inter-
phase phosphorylation of histone H3 Ser10 in interphase cells
(Deng et al. 2005). The dosage compensation pathway is re-
quired for increasing transcription from the single male X
through recruitment of the Male Speciﬁc Lethal (MSL) com-
plex, which leads to increased acetylation of lysine 16 of
histone H4 (H4K16ac) (Gelbart and Kuroda 2009; Conrad
and Akhtar 2011). To investigate whether the puffy X phe-
notype in Top2 mutant males resulted from altered dosage
compensation, we examined X chromosome localization of
components of the MSL complex in Top217-5/Top2Df9043 and
Top235-14/Top2Df9043 male larvae. We found that loss of Top2
neither affects recruitment of MSL1, MLE, or JIL-1 nor alters
enrichment of H4K16ac on the male X chromosome (Figure
5, D–F and G–I; data not shown).
Previous studies demonstrated that Imitation Switch
(ISWI) regulates higher-order chromatin structure that in-
cludes global decondensation of salivary gland polytene
chromosomes, with the male X chromosome displaying in-
creased sensitivity relative to the autosomes (Deuring et al.
2000). These processes are linked to defects in nucleosome
assembly due to reduced levels of histone H1 (Corona et al.
2007; Siriaco et al. 2009). Based on the similarity between
the Top2 and Iswi mutant phenotypes, coupled with the pre-
viously recognized functional interaction between Top2
and H1 (Hsieh and Brutlag 1980), we reasoned that changes
in polytene chromosome structure in Top2 mutants might
result from changes in H1 levels. To this end, salivary gland
proteins were isolated from Top2+/Top2Df9043, Top217-5/
Top2Df9043, and Top235-14/Top2Df9043 larvae and assessed
for H1 levels, using Western analyses. These studies demon-
strated that H1 accumulates at near wild-type levels (data
not shown), suggesting that loss of Top2 does not affect H1
production. It remains possible that loss of Top2 alters H1
deposition, a possibility that we were unable to test due to
the inability of our H1 antibodies to work in immunohisto-
chemical analyses.
Top2 mutations display interallelic complementation
Previous in vitro studies have demonstrated that Top2 sub-
units can undergo cooperative interactions to overcome de-
fective ATP binding by one subunit (Lindsley and Wang
1993). Based on these ﬁndings, we predicted that missense
Table 2 Analysis of survival of Top2m/Top2Df9043 larvae at 25
Allele namea Allele classiﬁcation % pupationb
Top2+ Wild-type 98b (100)c
Df 17 Deletion 49 (106)
Df 35 Deletion 66 (103)
17-1 Missense 73 (100)
17-2 Missense 72 (100)
17-3 Missense 92 (120)
17-5 Missense, 51 (142)
Nonsense
17-6 Missense 80 (120)
17-7 Nonsense 49 (135)
35-1 Missense 82 (100)
35-2 Nonsense 66 (110)
35-3 Missense 26 (141)
35-5 Missense 88 (100)
35-6 Missense 83 (100)
35-12 Missense 80 (100)
35-13 Missense 82 (136)
35-14 Nonsense 38 (104)
Boldface type indicates hypomorphic alleles, strains that showed signiﬁcant viability
(P , 0.04) relative to both Top2Df17 and Top2Df35.
a Maternally transmitted mutant Top2m, paternally transmitted mutant Top2Df9043.
b Percentage of pupation was determined by dividing the total number of observed
pupae by the total number of larvae placed in each vial, multiplied by 100.
c Total number scored.
Complementation of Novel Top2 Alleles 851
alleles encoding Top2 proteins with mutations in distinct
functional domains might display interallelic complementa-
tion. To this end, we conducted pairwise complementation
tests between all Top2 alleles, assaying each cross for the
production of viable adults. Initial crosses determined that 6
of the 14 lethal alleles supported interallelic complementa-
tion, generating Top2m1/Top2m2 adults (data not shown). We
refer to these progeny as Top2-complementing adults. To de-
termine the extent of complementation, we retested the 6
alleles, conducting crosses in both directions and scoring pro-
geny daily (Table 3). Twenty-six crosses produced adults,
revealing 13 heteroallelic genotypes capable of interallelic
complementation. Based on the number of Top2m heterozy-
gous siblings obtained in each complementation cross, we
estimate that the viability of Top2m1/Top2m2 adults ranged
from 13% to 98% (Table 3). Over half of all mutant geno-
types displayed .50% viability of Top2m1/Top2m2 adults, in-
dicating that interallelic complementation is robust.
Several conclusions were made from our inter se crosses.
First, none of the nonsense alleles demonstrated interallelic
complementation, suggesting that complementation requires
full-length proteins. Second, alleles capable of interallelic
complementation produced intermediate to high levels of
Top2 protein (Table 1 and Figure 3). Even so, an absolute
correlation between protein levels and complementation
was not observed. For example, Top217-1 complemented sev-
eral alleles, even though Top217-1 produces very low levels
of protein, while Top235-6 failed to complement any allele,
but produced intermediate levels of protein (Table 1 and
Figure 3). Third, interallelic complementation occurred be-
tween alleles encoding proteins altered in different functional
domains. For example, Top2 alleles encoding proteins with
defects in the TOPRIM domain complemented alleles encod-
ing proteins with defects in the ATPase domain or WHD
(Table 3). Fourth, complementation was observed between
alleles encoding proteins with defects in the same domain.
Remarkably, complementation occurred between Top2 mu-
tants carrying amino acid substitutions separated by only six
residues in the TOPRIM domain (Top217-3/Top235-1). These
studies provide the ﬁrst demonstration that Top2 mutants
can form a functional heterodimer in vivo and suggest that
signiﬁcant cooperation can occur between defective Top2
subunits to restore in vivo function.
Top2-complementing adults show limited
developmental defects
We studied progeny from inter se crosses between Top2 mis-
sense alleles to understand the extent of restored Top2 func-
tion. In general, we found that Top2-complementing adults
emerged at least 1 day later and died earlier than did their
Figure 5 Loss of Top2 affects chromosome structure. Sal-
ivary gland polytene chromosomes were prepared from
male third-instar larvae representing wild-type [Top2+/
Top2Df9043 (A, D, and G)] or mutant [Top217-5/Top2Df9043
(B, E, and H) and Top235-14/Top2Df9043 (C, F, and I)] Top2
genotypes. Chromosomes were stained with DAPI (A–C),
with enlargement of the male X chromosome shown to
demonstrate the diffuse DNA-banding pattern (A9–C9). Re-
cruitment of the MSL complex was assessed using anti-
bodies speciﬁc to MSL-1 (D–F) and H4K16ac (G–I).
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wild-type siblings. Nonetheless, these adults were morpholog-
ically normal, including having a body size that was similar to
that of Top2+ ﬂies. Unexpectedly, the F1 male-to-female ratio
in 5 of 26 crosses showed signiﬁcant deviation from the ex-
pected 1:1 ratio, wherein a single sex represented $70% of
the offspring (Table S4). Higher numbers of male offspring
were observed in all but one case (Top217-3/Top217-6). These
ﬁndings are reminiscent of our observations that Top217-2/
Top2Df9043 males produced by growth at 18 are healthier
than Top217-2/Top2Df9043 females (Figure 4A). The reason
for the different viability of Top2-complementing males and
females is unclear.
We assessed the fertility associated with Top2-complement-
ing adults. In initial studies, fertility was judged by an ability of
Top2-complementing males or females to generate adult prog-
eny when mated to y1 w67c23; Sco/CyO ﬂies. This assay estab-
lished that male fertility was largely not affected, with the one
exception representing the heteroallelic genotype Top217-3/
Top235-1 (Table 4). In contrast, all Top2-complementing fe-
males were sterile. To investigate the cause of female sterility,
nonvirgin Top2-complementing females were placed in vials,
which were examined for egg production. We found that all
Top2m1/Top2m2 females produced low numbers of eggs. None
of these eggs hatched, although their appearance was normal.
As activation of a meiotic checkpoint is linked to defects in
eggshell patterning (Morris and Lehmann 1999), these ﬁnd-
ings suggest that oogenesis in Top2-complementing females
occurs without checkpoint activation. Eggs from Top235-5/
Top235-13- and Top217-6/Top235-1-complementing females
were collected and stained with DAPI. Imaging using confocal
microscopy showed that the vast majority of eggs did not un-
dergo nuclear divisions (90 of 95 and 30 of 31, respectively).
While the lack of development may have resulted from a lack
of fertilization, the observation that a few eggs displayed evi-
dence of nuclear division suggests that fertilization could oc-
cur. We consider that compromised Top2 activity may lead
Table 3 Interallelic complementation between Top2 mutants y1w67c23/Y; Top2m/CyO, y+ · y1w67c23/ y1w67c23; Top2m/CyO, y+
Allele transmitted by female
Allele transmitted by male
17-1
WHD
17-3
TOPRIM
17-6
TOPRIM
35-1a
TOPRIM
35-5
ATPase
35-13
WHD
17-1 0b (165)c 19 (275) 13 (354) 56 (612) 95 (217) 0 (220)
WHD
17-3 22 (932) 2 (163) 64 (311) 22 (719) 93 (323) 77 (183)
TOPRIM
17-6 26 (214) 52 (243) 0 (248) 58 (708) 3 (147) 76 (208)
TOPRIM
35-1 46 (557) 31 (705) 71 (627) 0 (98) 78 (226) 85 (360)
TOPRIM
35-5 85 (220) 88 (440) 2 (777) 86 (346) 0 (103) 64 (426)
ATPase
35-13 0 (184) 60 (350) 55 (268) 79 (655) 98 (240) 0 (275)
WHD
Boldface type, 11–100% viability. Vials were scored daily.
a Top235-1 has three amino acid changes; however, only one change is in an invariant amino acid (P465S in TOPRIM domain).
b Percentage of viability is the number of Cy+ ﬂies divided by half the number of Cy2 ﬂies multiplied by 100.
c Total number of Cy2 ﬂies scored.
Table 4 Fertility of complementing Top2 adults
Allele transmitted by female (F)
Allele transmitted
by male (M)
17-1
WHD
17-3
TOPRIM
17-6
TOPRIM
35-1
TOPRIM
35-5
ATPase
35-13
WHD
17-1 NA F NA F NA F sterile F NA NA
WHD M fertile M fertile M fertile M fertile
17-3 F NA NA F sterile F sterile F sterile F sterile
TOPRIM M fertile M fertile M sterile M fertile M fertile
17-6 F sterile F sterile NA F sterile NA F sterile
TOPRIM M fertile M fertile M fertile M fertile
35-1 F sterile F sterile F sterile NA F sterile F sterile
TOPRIM M fertile M sterile M fertile M fertile M fertile
35-5 F NA F sterile NA F sterile NA F sterile
ATPase M fertile M fertile M fertile M fertile
35-13 NA F sterile F sterile F sterile F sterile NA
WHD M fertile M fertile M fertile M fertile
NA, not assessed. Males were considered fertile if any progeny eclosed; females were considered fertile if they produced eggs that hatched.
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to defects in transcription during oogenesis, causing deple-
tion of maternal products needed in embryogenesis. Alter-
natively, these eggs may carry defects in meiosis that inhibit
embryogenesis.
Low egg production prompted us to examine the ovary
phenotype in Top217-6/Top235-1-complementing females.
While strings of developing egg chambers were observed,
the ovaries were smaller and disorganized and contained evi-
dence of egg chamber apoptosis (Figure 6A). Effects of lowered
Top2 function on the germline stem cell (GSC) niche were ex-
amined by staining with antibodies against Vasa, a germline-
speciﬁc RNA helicase (Lasko and Ashburner 1988), and
Spectrin, a structural protein expressed in a cell-type–speciﬁc
pattern in all cells of the germarium. In germ cells, Spectrin
accumulates in a spherical structure in the GSCs, called the
spectrosome, and a branched structure in differentiating
cysts, called the fusome, while in somatic cells, Spectrin local-
izes within the plasma membrane (Lin et al. 1994). We found
that Top217-6/Top235-1 ovaries had complex defects in the
germaria, including the presence of germaria showing both
loss and gain of GSCs (Figure 6B). Taken together, these
analyses indicate that germ cell differentiation is compromised
in Top2-complementing females, leading to germ cell loss and
defects in egg chamber formation.
Concluding perspectives
Type II topoisomerases are molecular targets for chemother-
apy against several types of cancers (Nitiss 2009b; Chikamori
et al. 2010). However, treatment of cells with Top2 chemo-
therapeutic agents can produce drug-resistant forms of the
enzyme. For example, treatment of bacteria, yeast, and hu-
man cells with chemotherapeutic agents has caused Top2
mutations that alter drug binding, DNA binding, or catalytic
function (Nitiss 2009b; Wu et al. 2011). These drug-resis-
tant forms of the protein commonly contain amino acid sub-
stitutions in the N-terminal ATPase and TOPRIM domains
and the WHD. Interestingly, four of our Top2 missense
alleles carry changes in amino acid residues previously
found to be associated with drug resistance (Nitiss 2009b;
Wu et al. 2011). These include Top217-3, Top235-1, Top235-6,
and Top 35-12, mutations that have alterations in the TOPRIM
domain and the WHD (Table 1) and correspond to residues
L491, P485, S763, and G760 in human TopIIa, respectively.
Among these mutations, Top217-3 and Top235-1 are hypomor-
phic alleles that support interallelic complementation, sug-
gesting that certain heterodimers of drug-resistant proteins
may similarly reconstitute enough Top2 function for viability.
Based on these data, it is possible that individuals carry Top2
variants composed of defective monomers, which might con-
fer different sensitivities to inhibitors and affect treatment
outcomes.
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Figure 6 Top2-complementing females show
complex ovary phenotypes. (A) Wild-type and
heteroallelic Top217-6/Top235-1 mutant ovaries
were dissected from 3-day-old females and stained
with DAPI. The ovaries of Top2-complementing
females were smaller than wild-type ovaries,
but still retained strings of developing egg
chambers. Bars, 25 mm. (B) Wild-type and het-
eroallelic Top217-6/Top235-1 3-day-old ovaries
were stained with DAPI and with antibodies
against Vasa (red) to mark germ cells or with
Spectrin (green) to mark spectrosomes (aster-
isks) present in germline stem cells and fuso-
somes (arrowheads) present in differentiating
germ cells. Ovaries from the Top2-complement-
ing females contained disorganized germaria
(G), with a single ovary having germaria ﬁlled only
with germ cells containing spectrosomes and ger-
maria devoid of germ cells. Bars, 100 mm.
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Table	  S1	  	  	  Primer	  sequences	  used	  for	  PCR	  amplification	  and	  genomic	  sequencing	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
a	  Primers	  are	  relative	  to	  the	  transcription	  start	  site	  (+1).	  
	   	  
Primer	  Name	   Sequence	  (5’	  to	  3’)	  
Top2F	  +	  1031a	   TTAACTGGGTGGGTACTGTAGTCTTCTG	  	  
Top2R	  +	  1703	   AACGGTGAAGCTGGTGGAGAATATG	  	  
Top2F	  +	  1545	   TGACCATGCACAAGGAGCAGAAG	  	  
Top2R	  +	  2356	   ACCTGGAATGGCTTGATGTTGATGC	  	  
Top2F	  +	  2145	   TCCAACAGGTCTCGTTTGTCAACTC	  	  
Top2R	  +	  2924	   GCCATCCTGATCCTGATCTGTC	  	  
Top2F	  +	  2773	   TAATTTCAAGCAGCTTTCGGAGAATG	  	  
Top2R	  +	  3483	   AAGTGAACATCACCTTCCGCTGAC	  	  
Top2F	  +	  3362	   ATCACCTATGCAGACTTTATCAATCTGG	  	  
Top2R	  +	  4061	   TTCACTGATTTCTAAACGGTTTCCG	  	  
Top2F	  +	  3959	   TACAAGAACTTTTTAGGACGCATGG	  	  
Top2R	  +	  4657	   TTCTTAGCCTTTGAGCTGACACTGG	  	  
Top2F	  +	  4534	   ATATCGTCCCGATCCCGTCAAG	  	  
Top2R	  +	  5222	   ATCAAATTCGTCCACCTCATCG	  	  
Top2F	  +	  5035	   ACCCGTCGAGTTTAAGATCACCGAAG	  
Top2R	  +	  5379	   CTGAAACACTTACCTTGGCCTTGCTG	  	  
Top2F	  +	  5157	   AACCGAAGGGCAAGCAGATTAAAGC	  	  
Top2R	  +	  6249	   CCTTTATTTCCCACTTTCCGATTTGTG	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Table	  S2	  	  	  Complementation	  tests	  to	  define	  Top2	  alleles	  y1w67c23;	  Top2m/CyO,	  y+	  x	  y1w67c23;	  Top2Df9043/CyO,	  y+	  
	  
	   18°C	   25°C	   25°C	  
	   Maternally	  transmitted	  
allele	  
Maternally	  transmitted	  
allele	  
Paternally	  transmitted	  
allele	  
Allele	  Name	   %	  viabilitya	  
Df17	   ND	   0a	  (604)b	   0	  	  (196)	  
Df35	   ND	   0	  (424)	   0	  (695)	  
17-­‐1	   	  	  	  1	  	  	  	  (710)	  c	   0	  (359)	   	  0	  	  (412)	  
17-­‐2	   	  	  	  29	  	  	  	  (906)	  c,	  d	   0	  (193)	   0	  (170)	  
17-­‐3	   0	  	  	  	  (737)	   0	  (263)	   0	  (189)	  
17-­‐4	   ND	   	  	  	  	  	  	  	  	  137	  (249)	   	  	  	  	  	  	  	  	  	  110	  (122)	  
17-­‐5	   0	  	  	  	  (895)	   0	  (430)	   0	  (287)	  
17-­‐6	   0	  	  	  	  (939)	   0	  (207)	   0	  (295)	  
17-­‐7	   0	  	  	  	  (467)	   0	  (211)	   0	  (389)	  
35-­‐1	   0	  	  	  	  (535)	   0	  (300)	   0	  	  	  (99)	  
35-­‐2	   0	  	  	  	  (874)	   0	  (289)	   0	  (104)	  
35-­‐3	   0	  	  	  	  (898)	   0	  (283)	   0	  (102)	  
35-­‐4	   ND	   25	  (438)	   87	  (453)	  
35-­‐5	   0	  	  	  (803)	   	  	  0	  (423)	   	  	  0	  (815)	  
35-­‐6	   0	  	  	  	  (631)	   	  	  0	  (120)	   	  	  0	  (160)	  
35-­‐7	   ND	   	  	  	  	  	  	  	  	  	  127	  (229)	   159	  (208)	  
35-­‐8	   ND	   	  	  	  	  	  	  	  	  	  118	  (320)	   113	  (238)	  
35-­‐9	   ND	   205	  (112)	   124	  (302)	  
35-­‐12	   0	  	  	  	  (703)	   	  	  	  	  0	  	  	  (69)	   	  	  0	  (207)	  
35-­‐13	   0	  	  	  	  (611)	   	  	  	  	  0	  (115)	   	  	  0	  (218)	  
35-­‐14	   0	  (1065)	   	  	  	  	  0	  (226)	   	  	  0	  (162)	  
	  
a	  Percent	  viability	  is	  the	  #	  of	  Cy+	  flies	  divided	  by	  half	  the	  #	  of	  Cy-­‐	  flies	  multiplied	  by	  100.	  	  	  
b	  Total	  #	  of	  Cy-­‐	  flies	  scored.	  
c	  Top2m/Top2Df9043	  flies	  become	  stuck	  in	  food.	  
d	  Top217-­‐2/	  Top2Df9043	  males	  are	  sterile;	  females	  immediately	  become	  stuck	  in	  food.	  	  
ND:	  Not	  determined.	  
Bold	  indicates	  the	  fourteen	  lethal	  alleles	  at	  25°C.	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Table	  S3	  	  	  Numbers	  of	  progeny	  obtained	  from	  rescue	  crosses	  using	  the	  P[Top2-­‐w+]	  transgene	  y1w67c23;	  Top2Df35/CyO;	  
P[Top2-­‐w+]/+	  x	  y1w67c23/Y;	  Top2m/CyO,	  y+	  
	  
	  
	  
Allele	  transmitted	  by	  female	   	  
Allele	  
transmitted	  
by	  male	  
Top2m/Top2Df35;	  +/+	   Top2
m/Top2Df35;	  P[Top2-­‐
w+]/+	  
Top2m	  or	  Df35/CyO	  or	  CyO,	  y+;	  
P[Top2-­‐w+]/+	  
%	  Viabilitya	  
	  
Df17	   0	   32	   	  74	   	  86a(146)b	  
Df35	   0	   26	   	  82	   63	  (161)	  
17-­‐1	   0	   45	   	  90	   100	  (185)	  
17-­‐2	   0	   67	   101	   133	  (213)	  
17-­‐3	   0	   30	   	  	  56	   107	  (127)	  
17-­‐5	   0	   72	   130	   111	  (256)	  
17-­‐6	   0	   44	   105	   	  	  84	  (205)	  
17-­‐7	   0	   79	   130	   122	  (269)	  
35-­‐1	   0	   40	   	  	  76	   105	  (157)	  
35-­‐2	   0	   53	   	  	  76	   139	  (129)	  
35-­‐3	   0	   48	   	  	  68	   141	  (154)	  
35-­‐5	   0	   37	   	  	  64	   116	  (131)	  
35-­‐6	   0	   35	   	  	  64	   109	  (155)	  
35-­‐12	   0	   38	   	  	  69	   110	  (124)	  
35-­‐13	   0	   58	   110	   105	  (210)	  
35-­‐14	   0	   78	   127	   123	  (280)	  
	  
a	  %	  viability	  is	  the	  #	  of	  Cy+,	  P[Top2-­‐w+]	  flies	  divided	  by	  half	  the	  #	  of	  Cy-­‐,	  P[Top2,	  w+]/+	  flies	  multiplied	  by	  100.	  
bTotal	  #	  of	  Cy-­‐	  flies	  scored.	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  Table	  S4	  	  	  Percentage	  of	  male	  and	  female	  offspring	  of	  viable	  heteroallelic	  Top2	  genotypes	  
	  
	   Allele	  transmitted	  by	  female	  
Allele	  
transmitted	  by	  
male	  
	  
17-­‐1	  
WHD	  
	  
	  
17-­‐3	  
TOPRIM	  
	  
	  
17-­‐6	  
TOPRIM	  
	  
35-­‐1	  
TOPRIM	  
	  
35-­‐5	  
ATPase	  
	  
	  
35-­‐13	  
WHD	  
	  
17-­‐1	  
WHD	  
	  
NA	  
F:	  	  	  	  9	  
M:	  91	  
(23)a	  
F:	  	  42	  
M:	  58	  
(24)	  
F:	  	  47	  
M:	  53	  
(139)	  
F:	  50	  
M:	  50	  
(105)	  
NA	  
17-­‐3	  
TOPRIM	  
	  
F:	  12	  
M:	  88	  
(101)	  
NA	  
F:	  	  53	  
M:	  47	  
(97)	  
F:	  	  57	  
M:	  43	  
(70)	  
F:	  	  41	  
M:	  59	  
(143)	  
F:	  	  30	  
M:	  70	  
(69)	  
17-­‐6	  
TOPRIM	  
	  
F:	  60	  
M:	  40	  
(30)	  
F:	  	  76	  
M:	  24	  
(63)	  
NA	  
F:	  	  48	  
M:	  52	  
(190)	  
NA	  
F:	  	  27	  
M:	  73	  
(79)	  
35-­‐1	  
TOPRIM	  
	  
F:	  44	  
M:	  56	  
(108)	  
F:	  59	  
M:	  41	  
(74)	  
F:	  57	  
M:	  43	  
(205)	  
NA	  
F:	  	  51	  
M:	  49	  
(92)	  
F:	  	  43	  
M:	  57	  
(143)	  
35-­‐5	  
ATPase	  
	  
F:	  	  51	  
M:	  49	  
(94)	  
F:	  	  45	  
M:	  55	  
(145)	  
NA	  
F:	  	  45	  
M:	  55	  
(154)	  
NA	  
F:	  	  38	  
M:	  62	  
(125)	  
35-­‐13	  
WHD	  
	  
NA	  
F:	  	  38	  
M:	  62	  
(93)	  
F:	  	  47	  
M:	  53	  
(73)	  
F:	  	  46	  
M:	  54	  
(228)	  
F:	  	  57	  
M:	  43	  
(115)	  
NA	  
	  
aTotal	  number	  of	  homozygotes	  scored.	  	  	  
NA:	  Not	  applicable.	  	  	  
Bold:	  statistically	  significant	  (p<0.05).	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Table	  S1	  	  	  Primer	  sequences	  used	  for	  PCR	  amplification	  and	  genomic	  sequencing	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
a	  Primers	  are	  relative	  to	  the	  transcription	  start	  site	  (+1).	  
	   	  
Primer	  Name	   Sequence	  (5’	  to	  3’)	  
Top2F	  +	  1031a	   TTAACTGGGTGGGTACTGTAGTCTTCTG	  	  
Top2R	  +	  1703	   AACGGTGAAGCTGGTGGAGAATATG	  	  
Top2F	  +	  1545	   TGACCATGCACAAGGAGCAGAAG	  	  
Top2R	  +	  2356	   ACCTGGAATGGCTTGATGTTGATGC	  	  
Top2F	  +	  2145	   TCCAACAGGTCTCGTTTGTCAACTC	  	  
Top2R	  +	  2924	   GCCATCCTGATCCTGATCTGTC	  	  
Top2F	  +	  2773	   TAATTTCAAGCAGCTTTCGGAGAATG	  	  
Top2R	  +	  3483	   AAGTGAACATCACCTTCCGCTGAC	  	  
Top2F	  +	  3362	   ATCACCTATGCAGACTTTATCAATCTGG	  	  
Top2R	  +	  4061	   TTCACTGATTTCTAAACGGTTTCCG	  	  
Top2F	  +	  3959	   TACAAGAACTTTTTAGGACGCATGG	  	  
Top2R	  +	  4657	   TTCTTAGCCTTTGAGCTGACACTGG	  	  
Top2F	  +	  4534	   ATATCGTCCCGATCCCGTCAAG	  	  
Top2R	  +	  5222	   ATCAAATTCGTCCACCTCATCG	  	  
Top2F	  +	  5035	   ACCCGTCGAGTTTAAGATCACCGAAG	  
Top2R	  +	  5379	   CTGAAACACTTACCTTGGCCTTGCTG	  	  
Top2F	  +	  5157	   AACCGAAGGGCAAGCAGATTAAAGC	  	  
Top2R	  +	  6249	   CCTTTATTTCCCACTTTCCGATTTGTG	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Table	  S2	  	  	  Complementation	  tests	  to	  define	  Top2	  alleles	  y1w67c23;	  Top2m/CyO,	  y+	  x	  y1w67c23;	  Top2Df9043/CyO,	  y+	  
	  
	   18°C	   25°C	   25°C	  
	   Maternally	  transmitted	  
allele	  
Maternally	  transmitted	  
allele	  
Paternally	  transmitted	  
allele	  
Allele	  Name	   %	  viabilitya	  
Df17	   ND	   0a	  (604)b	   0	  	  (196)	  
Df35	   ND	   0	  (424)	   0	  (695)	  
17-­‐1	   	  	  	  1	  	  	  	  (710)	  c	   0	  (359)	   	  0	  	  (412)	  
17-­‐2	   	  	  	  29	  	  	  	  (906)	  c,	  d	   0	  (193)	   0	  (170)	  
17-­‐3	   0	  	  	  	  (737)	   0	  (263)	   0	  (189)	  
17-­‐4	   ND	   	  	  	  	  	  	  	  	  137	  (249)	   	  	  	  	  	  	  	  	  	  110	  (122)	  
17-­‐5	   0	  	  	  	  (895)	   0	  (430)	   0	  (287)	  
17-­‐6	   0	  	  	  	  (939)	   0	  (207)	   0	  (295)	  
17-­‐7	   0	  	  	  	  (467)	   0	  (211)	   0	  (389)	  
35-­‐1	   0	  	  	  	  (535)	   0	  (300)	   0	  	  	  (99)	  
35-­‐2	   0	  	  	  	  (874)	   0	  (289)	   0	  (104)	  
35-­‐3	   0	  	  	  	  (898)	   0	  (283)	   0	  (102)	  
35-­‐4	   ND	   25	  (438)	   87	  (453)	  
35-­‐5	   0	  	  	  (803)	   	  	  0	  (423)	   	  	  0	  (815)	  
35-­‐6	   0	  	  	  	  (631)	   	  	  0	  (120)	   	  	  0	  (160)	  
35-­‐7	   ND	   	  	  	  	  	  	  	  	  	  127	  (229)	   159	  (208)	  
35-­‐8	   ND	   	  	  	  	  	  	  	  	  	  118	  (320)	   113	  (238)	  
35-­‐9	   ND	   205	  (112)	   124	  (302)	  
35-­‐12	   0	  	  	  	  (703)	   	  	  	  	  0	  	  	  (69)	   	  	  0	  (207)	  
35-­‐13	   0	  	  	  	  (611)	   	  	  	  	  0	  (115)	   	  	  0	  (218)	  
35-­‐14	   0	  (1065)	   	  	  	  	  0	  (226)	   	  	  0	  (162)	  
	  
a	  Percent	  viability	  is	  the	  #	  of	  Cy+	  flies	  divided	  by	  half	  the	  #	  of	  Cy-­‐	  flies	  multiplied	  by	  100.	  	  	  
b	  Total	  #	  of	  Cy-­‐	  flies	  scored.	  
c	  Top2m/Top2Df9043	  flies	  become	  stuck	  in	  food.	  
d	  Top217-­‐2/	  Top2Df9043	  males	  are	  sterile;	  females	  immediately	  become	  stuck	  in	  food.	  	  
ND:	  Not	  determined.	  
Bold	  indicates	  the	  fourteen	  lethal	  alleles	  at	  25°C.	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Table	  S3	  	  	  Numbers	  of	  progeny	  obtained	  from	  rescue	  crosses	  using	  the	  P[Top2-­‐w+]	  transgene	  y1w67c23;	  Top2Df35/CyO;	  
P[Top2-­‐w+]/+	  x	  y1w67c23/Y;	  Top2m/CyO,	  y+	  
	  
	  
	  
Allele	  transmitted	  by	  female	   	  
Allele	  
transmitted	  
by	  male	  
Top2m/Top2Df35;	  +/+	   Top2
m/Top2Df35;	  P[Top2-­‐
w+]/+	  
Top2m	  or	  Df35/CyO	  or	  CyO,	  y+;	  
P[Top2-­‐w+]/+	  
%	  Viabilitya	  
	  
Df17	   0	   32	   	  74	   	  86a(146)b	  
Df35	   0	   26	   	  82	   63	  (161)	  
17-­‐1	   0	   45	   	  90	   100	  (185)	  
17-­‐2	   0	   67	   101	   133	  (213)	  
17-­‐3	   0	   30	   	  	  56	   107	  (127)	  
17-­‐5	   0	   72	   130	   111	  (256)	  
17-­‐6	   0	   44	   105	   	  	  84	  (205)	  
17-­‐7	   0	   79	   130	   122	  (269)	  
35-­‐1	   0	   40	   	  	  76	   105	  (157)	  
35-­‐2	   0	   53	   	  	  76	   139	  (129)	  
35-­‐3	   0	   48	   	  	  68	   141	  (154)	  
35-­‐5	   0	   37	   	  	  64	   116	  (131)	  
35-­‐6	   0	   35	   	  	  64	   109	  (155)	  
35-­‐12	   0	   38	   	  	  69	   110	  (124)	  
35-­‐13	   0	   58	   110	   105	  (210)	  
35-­‐14	   0	   78	   127	   123	  (280)	  
	  
a	  %	  viability	  is	  the	  #	  of	  Cy+,	  P[Top2-­‐w+]	  flies	  divided	  by	  half	  the	  #	  of	  Cy-­‐,	  P[Top2,	  w+]/+	  flies	  multiplied	  by	  100.	  
bTotal	  #	  of	  Cy-­‐	  flies	  scored.	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  Table	  S4	  	  	  Percentage	  of	  male	  and	  female	  offspring	  of	  viable	  heteroallelic	  Top2	  genotypes	  
	  
	   Allele	  transmitted	  by	  female	  
Allele	  
transmitted	  by	  
male	  
	  
17-­‐1	  
WHD	  
	  
	  
17-­‐3	  
TOPRIM	  
	  
	  
17-­‐6	  
TOPRIM	  
	  
35-­‐1	  
TOPRIM	  
	  
35-­‐5	  
ATPase	  
	  
	  
35-­‐13	  
WHD	  
	  
17-­‐1	  
WHD	  
	  
NA	  
F:	  	  	  	  9	  
M:	  91	  
(23)a	  
F:	  	  42	  
M:	  58	  
(24)	  
F:	  	  47	  
M:	  53	  
(139)	  
F:	  50	  
M:	  50	  
(105)	  
NA	  
17-­‐3	  
TOPRIM	  
	  
F:	  12	  
M:	  88	  
(101)	  
NA	  
F:	  	  53	  
M:	  47	  
(97)	  
F:	  	  57	  
M:	  43	  
(70)	  
F:	  	  41	  
M:	  59	  
(143)	  
F:	  	  30	  
M:	  70	  
(69)	  
17-­‐6	  
TOPRIM	  
	  
F:	  60	  
M:	  40	  
(30)	  
F:	  	  76	  
M:	  24	  
(63)	  
NA	  
F:	  	  48	  
M:	  52	  
(190)	  
NA	  
F:	  	  27	  
M:	  73	  
(79)	  
35-­‐1	  
TOPRIM	  
	  
F:	  44	  
M:	  56	  
(108)	  
F:	  59	  
M:	  41	  
(74)	  
F:	  57	  
M:	  43	  
(205)	  
NA	  
F:	  	  51	  
M:	  49	  
(92)	  
F:	  	  43	  
M:	  57	  
(143)	  
35-­‐5	  
ATPase	  
	  
F:	  	  51	  
M:	  49	  
(94)	  
F:	  	  45	  
M:	  55	  
(145)	  
NA	  
F:	  	  45	  
M:	  55	  
(154)	  
NA	  
F:	  	  38	  
M:	  62	  
(125)	  
35-­‐13	  
WHD	  
	  
NA	  
F:	  	  38	  
M:	  62	  
(93)	  
F:	  	  47	  
M:	  53	  
(73)	  
F:	  	  46	  
M:	  54	  
(228)	  
F:	  	  57	  
M:	  43	  
(115)	  
NA	  
	  
aTotal	  number	  of	  homozygotes	  scored.	  	  	  
NA:	  Not	  applicable.	  	  	  
Bold:	  statistically	  significant	  (p<0.05).	  	  
	  
	  	  
	  
